Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects. (Q40927752)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

8

J S Harmatz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

2

D J Greenblatt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1

L L von Moltke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

J M Grassi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

B W Granda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K Venkatakrishnan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S X Duan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S M Fogelman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

839-849

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors.

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Use of cDNA-expressed human cytochrome P450 enzymes to study potential drug-drug interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Inhibition of human cytochrome P450-3A isoforms by fluoxetine and norfluoxetine: in vitro and in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

The emerging role of cytochrome P450 3A in psychopharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

The effects of selective serotonin reuptake inhibitors and their metabolites on S-mephenytoin 4'-hydroxylase activity in human liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Drug interactions of clinical significance with selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Inhibition by fluoxetine of cytochrome P450 2D6 activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Pharmacokinetic interaction study of citalopram and cimetidine in healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Metabolism of dextromethorphan in vitro: involvement of cytochromes P450 2D6 and 3A3/4, with a possible role of 2E1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Characterization of six in vitro reactions mediated by human cytochrome P450: application to the testing of cytochrome P450-directed antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p-hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

The clinician and drug interactions--an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Inhibitors of imipramine metabolism by human liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Relative quantities of catalytically active CYP 2C9 and 2C19 in human liver microsomes: application of the relative activity factor approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Human cytochromes mediating N-demethylation of fluoxetine in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

In vitro approaches to predicting drug interactions in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900353-9

10.1016/S0006-3223(98)00353-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494454%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference